Finland· FI-EU-EU/1/97/039/003-004
Cystagon
A mercaptamine product, registered in Finland by Recordati Rare Diseases. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Mercaptamine · ATC A16AA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mercaptamine costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mercaptamine · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$589.95
The record
At a glance
Fimea (Finland)- Manufacturer
- Recordati Rare Diseases
- Country
- Finland (FI)
- ATC code
- A16AA04
- ATC class
- Mercaptamine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- June 4, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AA04
Mercaptamine, as other registers publish it.
- ItalyCYSTADROPS*collirio 5 ml 3,8 mg/mlRECORDATI RARE DISEASES SARL
- NorwayCystagonRecordati Rare Diseases
- IcelandCystagonRecordati Rare Diseases*
- FinlandCystagonRecordati Rare Diseases
- PolandCystagonRecordati Rare Diseases
- DenmarkCystagonRecordati Rare Diseases
- FinlandCystagonRecordati Rare Diseases
- IcelandCystagonRecordati Rare Diseases*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb48ca5b-e91c-4c0d-9967-78b72a9cd031 GET /v1/drugs/bb48ca5b-e91c-4c0d-9967-78b72a9cd031?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "kapseli, kova",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "150 mg",
"atc_label": "merkaptamiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/97/039/003-004",
"fimea_rel_id": "REL4492",
"authorised_at": "1997-06-23"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.